CERQUETTI, LIDIA
 Distribuzione geografica
Continente #
NA - Nord America 778
EU - Europa 160
AS - Asia 121
AF - Africa 18
SA - Sud America 7
OC - Oceania 1
Totale 1.085
Nazione #
US - Stati Uniti d'America 773
IT - Italia 69
SG - Singapore 54
IN - India 30
SE - Svezia 28
CN - Cina 27
FI - Finlandia 17
TG - Togo 17
DE - Germania 14
UA - Ucraina 8
AR - Argentina 5
CA - Canada 5
GB - Regno Unito 5
IE - Irlanda 5
JP - Giappone 4
RO - Romania 4
ID - Indonesia 3
IL - Israele 3
BE - Belgio 2
ES - Italia 2
LT - Lituania 2
BG - Bulgaria 1
BR - Brasile 1
CL - Cile 1
FR - Francia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SC - Seychelles 1
Totale 1.085
Città #
Fairfield 163
Ashburn 72
Houston 63
Seattle 59
Woodbridge 49
Cambridge 48
Wilmington 48
Singapore 43
Chandler 42
Rome 22
Ann Arbor 21
San Paolo di Civitate 21
Beijing 20
Princeton 19
Lomé 17
Plano 16
Santa Clara 15
Lawrence 14
Boston 10
Falls Church 8
Bremen 7
Millbury 7
Andover 6
San Diego 6
Dublin 5
Federal 5
Norwalk 5
Dearborn 4
Kitakyushu 4
Ariccia 3
Boardman 3
Jakarta 3
Mannheim 3
New York 3
Ottawa 3
Petah Tikva 3
Pune 3
Albolote 2
Brussels 2
Florence 2
Frankfurt am Main 2
Fremont 2
Grafing 2
Helsinki 2
London 2
Nanjing 2
Pereto 2
Roccabernarda 2
Toronto 2
Venice 2
Augusta 1
Colombes 1
Gallatin 1
Hamilton 1
Hebei 1
Hefei 1
Hyderabad 1
Jacksonville 1
Kunming 1
Mcallen 1
Milan 1
Perugia 1
Phoenix 1
Piatra Neamţ 1
Polska 1
San Mateo 1
Sofia 1
Southend 1
Tappahannock 1
Vitória 1
Totale 889
Nome #
Effect of mitotane on mouse ovarian follicle development and fertility 95
New insights and future perspectives in the therapeutic strategy of adrenocortical carcinoma (Review) 80
GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo 73
Proteomic profiles in hyperandrogenic syndromes 72
Modulation of proteomic profile in H295R adrenocortical cell line induced by mitotane 69
Human placenta-derived neurospheres are susceptible to transformation after extensive in vitro expansion 69
Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells 65
C-MYC modulation induces responsiveness to paclitaxel in adrenocortical cancer cell lines 65
Increased metastatic lymph node 64 and CYP17 expression are associated with high stage prostate cancer 64
Current and emerging therapeutic options in adrenocortical cancer treatment. 60
Mitotane sensitizes adrenocortical cancer cells to ionizing radiations by involvement of the cyclin B1/CDK complex in G2 arrest and mismatch repair enzymes modulation 60
Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: a case report 59
Effects of Sorafenib, a tyrosin kinase inhibitor, on adrenocortical cancer 58
Antineoplastic effect of a combined mitotane treatment/ionizing radiation in adrenocortical carcinoma: A preclinical study 55
Mitotane increases the radiotheraphy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines 45
p53 Stabilization Induces Cell Growth Inhibition and Affects IGF2 Pathway in Response to Radiotherapy in Adrenocortical Cancer Cells 44
Il trattamento farmacologico della sindrome di Cushing a etiologia surrenalica 38
Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: Potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment 37
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 36
Totale 1.144
Categoria #
all - tutte 3.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.108


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020238 0 0 0 0 31 39 45 37 37 23 20 6
2020/202179 7 8 7 2 0 6 1 3 18 8 4 15
2021/2022191 3 11 20 6 22 9 3 16 16 20 31 34
2022/2023202 37 52 8 19 21 20 6 7 17 6 5 4
2023/202472 4 15 1 9 2 9 0 5 2 6 11 8
2024/202582 1 26 8 19 28 0 0 0 0 0 0 0
Totale 1.144